Patent application number | Description | Published |
20140026892 | SURGICAL POSITIONING AID - A surgical positioning aid includes a sheet of foldable material foldable between a flat position and a wrist support position. In the wrist support position, the sheet is folded to form a hump having sufficient strength to support a patient's wrist in a hyper-extended position during surgery. The sheet also includes a coupler situated at a first end region of the sheet. The coupler is operable to engage an opposite, second end region of the sheet and to hold the sheet in the wrist support position. Many other surgical positioning aid embodiments are also disclosed. | 01-30-2014 |
20140068863 | Multi-Axis Joint for a Spar of a Limb Holder - A patient support apparatus includes a surgical table and a limb support unit coupled to the surgical table. The limb support unit includes a support platform coupled to the surgical table in a fixed position, a first limb holder coupled to the support platform in a fixed position relative to the support platform, and a second limb holder coupled to the support platform and spaced apart from the first limb holder. The first limb holder includes a multi-axis joint coupled to the support platform in a fixed position and a spar coupled to the multi-axis joint to move relative to the support platform while supporting a patient's limb that has been coupled to the spar. | 03-13-2014 |
20140068864 | Surgical Support System - A surgical table extension comprises a frame and a connector. The frame includes a surgical table connecting portion, a first connector, and a second connector. The connector enabler is movably coupled to the frame and is configured to selectively enable one of the first connector and the second connector to be removably coupled with a support device. | 03-13-2014 |
20140068866 | CARRIAGE FOR A SURGICAL BOOT OF A HIP DISTRACTOR - A carriage for a limb support includes a space for receiving a longitudinal member of a patient support apparatus, a plurality of rollers configured to engage the longitudinal member and a locking mechanism. The plurality of rollers is configured to maintain alignment of the carriage during movement of the carriage along the longitudinal member. The carriage also includes an elastomeric member that resists rotation to prevent unwanted motion of the carriage. The locking mechanism is configured to secure the carriage to the longitudinal member at any of an infinite number of positions along the length of the longitudinal member, the locking mechanism being lockable with a single action. | 03-13-2014 |
Patent application number | Description | Published |
20100299617 | IDENTITY MANAGEMENT FOR OPEN OVERLAY FOR SOCIAL NETWORKS AND ONLINE SERVICES - Methods and systems can manage the multiple identities used by a user. The user's existing contact lists, website accounts, buddy lists, and the like are analyzed to determine the identities used by the user. A graph is then constructed in order to track and integrate the multiple identities of the user in a social network. The social network graph may then be used by a social network overlay so that the user can share information across their different identities with different users that only know some of the user's multiple identities. | 11-25-2010 |
20120089732 | METHOD AND SYSTEM FOR ESTABLISHING A NEW ACCOUNT FOR A USER WITH AN ONLINE SERVICE - A user is provided a temporary account and, in the event they choose to finalize joining a service, the user is permitted to save settings from their temporary account. For example, in some embodiments, the user is permitted to perform various functions, such as, browsing the service, navigating external links, and viewing various pages of other users and groups. This information and links may be transitioned over if the user wishes to establish a permanent account. | 04-12-2012 |
20120136937 | AUTOMATED EVALUATION OF CONTENT BASED ON USER ACTIVITIES - Embodiments of the present invention provide an automated scheme for identifying high/low value content. Playback data from users in a social network may be periodically submitted by users of the social network. The playback data indicates segments of content, such as audio or video that the user has skipped over or tagged as low value. The playback data may also indicate segments of content that the user has repeated or tagged as high value. The playback data is then analyzed in aggregate and various clips are identified. In addition, the playback data may be compiled and organized among the users for future use. The playback data may be used to indicate segments of high/low interest to peers in the social network or to arbitrary users. | 05-31-2012 |
20120233263 | IDENTITY MANAGEMENT FOR OPEN OVERLAY FOR SOCIAL NETWORKS AND ONLINE SERVICES - Methods and systems to manage users of a social network. The method includes receiving, at a server, a request to contact a user from another user of a social network based on a selected one of a plurality of associated identity resources of the user known by other users. The method also includes restricting views of other users for the identity of the user to the selected one of the plurality of associated identity resources. | 09-13-2012 |
20140258422 | PROVIDING SOCIAL NETWORK USER DISCUSSIONS - Discussion of content between users of social networks is described. A request from a first user to discuss content with a recipient user in a first social network is received, wherein the recipient user has a first identifier in the first social network. A request from a second user to discuss content with the recipient user in a second social network is received, wherein the recipient user has a second identifier in the second social network. A discussion is initiated between the second user and the recipient user about the content in the second social network. The recipient user is tracked in view of the first identifier in the first social network and the second identifier in the second social network. | 09-11-2014 |
Patent application number | Description | Published |
20090144283 | SYSTEMS AND METHODS FOR GENERATING FILE USAGE INFORMATION - Embodiments relate to systems and methods for tracking local and remote file usage, and aggregating the resulting file usage statistics for presentation to a user. The operating system of a local computer can track and generate local file usage statistics, such as most recently used files and editing time. A Web application or service, such as an email or word processing application or service, can record the file usage data for a user's remote stored or served files. A file usage aggregator module, which can be located or resident in the operating system of the local computer or hosted at a Web site, can receive and combine the local and remote file usage statistics. The file usage aggregator module can generate a display of the aggregated file usage statistics, so that local and remote files are listed in a most-recently used order, on a combined basis. | 06-04-2009 |
20090222463 | SYSTEMS AND METHODS FOR A JOURNAL PAGE - An embodiment relates generally to a method of displaying information. The method includes monitoring any user activity within at least one application executing on a computer and detecting a completion of a user activity. The method also includes creating a link to the completed user activity and placing in the link in a time-ordered sequential basis in a journal section of a desktop of the computer. | 09-03-2009 |
20090222736 | SYSTEMS AND METHODS FOR A FILTER MODULE FOR A BROWSER HISTORY - An embodiment relates generally to a method of filtering for a browser. The method includes providing a browser with a browser history function, the browser history function configured to store each site web page visited and stored in time sequential order as a browser history. The method also includes providing a filter module for the browser; and applying the filter module to the browser history function to eliminate intermediary web pages from entering the browser history. | 09-03-2009 |
Patent application number | Description | Published |
20100016336 | HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE - The present disclosure relates to compounds effective as human protein tyrosine phosphatase beta (HPTP-β) inhibitors thereby regulating angiogenesis. The present disclosure further relates to compositions comprising said human protein tyrosine phosphatase beta (HPTP-β) inhibitors, and to methods for regulating angiogenesis. | 01-21-2010 |
20100069448 | HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE - The present disclosure relates to compounds effective as human protein tyrosine phosphatase beta (HPTP-β) inhibitors thereby regulating angiogenesis. The present disclosure further relates to compositions comprising said human protein tyrosine phosphatase beta (HPTP-β) inhibitors, and to methods for regulating angiogenesis. | 03-18-2010 |
20110212951 | HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE - The present disclosure relates to compounds effective as human protein tyrosine phosphatase beta (HPTP-β) inhibitors thereby regulating angiogenesis. The present disclosure further relates to compositions comprising said human protein tyrosine phosphatase beta (HPTP-β) inhibitors, and to methods for regulating angiogenesis. | 09-01-2011 |
20120077853 | HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE - The present disclosure relates to compounds effective as human protein tyrosine phosphatase beta (HPTP-β) inhibitors thereby regulating angiogenesis. The present disclosure further relates to compositions comprising one or more human protein tyrosine phosphatase beta (HPTP-β) inhibitors, and to methods for regulating angiogenesis. | 03-29-2012 |
20120077975 | HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHOD OF USE - The present disclosure relates to compounds effective as human protein tyrosine phosphatase beta (HPTP-β) inhibitors thereby regulating angiogenesis. The present disclosure further relates to compositions comprising said human protein tyrosine phosphatase beta (HPTP-β) inhibitors, and to methods for regulating angiogenesis. | 03-29-2012 |
20130023542 | HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE - The present disclosure relates to compounds effective as human protein tyrosine phosphatase beta (HPTP-β) inhibitors thereby regulating angiogenesis. The present disclosure further relates to compositions comprising said human protein tyrosine phosphatase beta (HPTP-β) inhibitors, and to methods for regulating angiogenesis. | 01-24-2013 |
20130023543 | HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE - The present disclosure relates to compounds effective as human protein tyrosine phosphatase beta (HPTP-β) inhibitors thereby regulating angiogenesis. The present disclosure further relates to compositions comprising said human protein tyrosine phosphatase beta (HPTP-β) inhibitors, and to methods for regulating angiogenesis. | 01-24-2013 |
20130096140 | HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE - The present disclosure relates to compounds effective as human protein tyrosine phosphatase beta (HPTP-β) inhibitors thereby regulating angiogenesis. The present disclosure further relates to compositions comprising said human protein tyrosine phosphatase beta (HPTP-β) inhibitors, and to methods for regulating angiogenesis. | 04-18-2013 |
20130324558 | HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE - The present disclosure relates to compounds effective as human protein tyrosine phosphatase beta (HPTP-β) inhibitors thereby regulating angiogenesis. The present disclosure further relates to compositions comprising said human protein tyrosine phosphatase beta (HPTP-β) inhibitors, and to methods for regulating angiogenesis. | 12-05-2013 |
20140221666 | HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE - The present disclosure relates to compounds effective as human protein tyrosine phosphatase beta (HPTP-β) inhibitors thereby regulating angiogenesis. The present disclosure further relates to compositions comprising said human protein tyrosine phosphatase beta (HPTP-β) inhibitors, and to methods for regulating angiogenesis. | 08-07-2014 |
20150210656 | HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE - The present disclosure relates to compounds effective as human protein tyrosine phosphatase beta (HPTP-β) inhibitors thereby regulating angiogenesis. The present disclosure further relates to compositions comprising said human protein tyrosine phosphatase beta (HPTP-β) inhibitors, and to methods for regulating angiogenesis. | 07-30-2015 |
Patent application number | Description | Published |
20080270438 | MEDICAL LABORATORY REPORT MESSAGE GATEWAY - A gateway enables medical (including genetic and genomic) laboratories and health care providers (collectively “clients”) to communicate electronic messages with each other without developing and maintaining an interface for each peer. The gateway translates messages sent between the parties. The gateway receives messages from each sender in a form, and containing diagnostic codes, preferred by the sender. For each received message, the gateway ascertains an intended receiving client. Each client may specify one or more receivers (such as applications) that are to receive messages sent to the client, as well as a separate form, and optionally a set of codes, for each receiver. For each receiver, the gateway generates translated messages, according to the receiver's preferred form and/or codes. The gateway sends the translated messages to each of the designated receivers. The gateway may include a validation component to check incoming messages to ensure the messages include required information and that information values are valid or acceptable. The gateway may include an exception handler that notifies a sending client if a message from the client fails to be translated or sent correctly. The gateway may maintain a repository in which the gateway stores copies of messages the gateway sent or would have sent to clients. The gateway provides an interface, such as a secure web interface, to this repository. Clients may access messages or lists of messages, especially messages the clients are not otherwise capable of receiving, through this interface. The gateway may store copies of some of the data that flows through the gateway in a bioinformatics database, which may be automatically analyzed by the gateway or queried for research or patient care purposes. | 10-30-2008 |
20110119309 | Medical Laboratory Report Message Gateway - A gateway enables medical (including genetic and genomic) laboratories and health care providers (collectively “clients”) to communicate electronic messages with each other without developing and maintaining an interface for each peer. The gateway translates messages sent between the parties. The gateway receives messages from each sender in a form, and containing diagnostic codes, preferred by the sender. For each received message, the gateway ascertains an intended receiving client. Each client may specify one or more receivers (such as applications) that are to receive messages sent to the client, as well as a separate form, and optionally a set of codes, for each receiver. For each receiver, the gateway generates translated messages, according to the receiver's preferred form and/or codes. The gateway sends the translated messages to each of the designated receivers. The gateway may include a validation component to cheek incoming messages to ensure the messages include required information and that information values are valid or acceptable. The gateway may include an exception handler that notifies a sending client if a message from the client fails to be translated or sent correctly. The gateway may maintain a repository in which the gateway stores copies of messages the gateway sent or would have sent to clients. The gateway provides an interface, such as a secure web interface, to this repository. Clients may access messages or lists of messages, especially messages the clients are not otherwise capable of receiving, through this interface. The gateway may store copies of some of the data that flows through the gateway in a bioinformatics database, which may be automatically analyzed by the gateway or queried for research or patient care purposes. | 05-19-2011 |
Patent application number | Description | Published |
20090246342 | METHOD FOR PROCESSING FLUID DAIRY, FRUIT OR VEGETABLE JUICES AND BEVERAGE CONCENTRATES FORMULATED FOR BEVERAGE PRODUCTS INTENDED FOR HUMAN CONSUMPTION TO PROTECT AGAINST DELIBERATE CONTAMINATION WITH PATHOGENIC AGROTERRORISM AGENTS - A method for purifying fluids without compromising the components of the fluid is disclosed. Fluid dairy, fruit, vegetable and/or beverage concentrates are processed using pasteurization and filtration steps selectively applied to separate phase-separated components of the fluid to eliminate contaminants including agro- and biological terrorism contaminants such as bacteria and viruses. | 10-01-2009 |
20110244076 | CARBONATED DAIRY NUTRIENT BEVERAGE AND METHOD OF MAKING A CARBONATED DAIRY NUTRIENT BEVERAGE TO SUPPLY THE SAME NUTRITION OF SKIM MILK IN THE HUMAN DIET - Carbonated dairy nutrient beverage solutions that supply essential nutrients in the human diet are disclosed. The solutions may contain per 8 oz., calcium, magnesium and potassium ions in the form of salts, vitamins A, D, C, and optionally lutein, zeaxanthin and folic acid in specified amounts to provide dietary supplementation. Sweeteners, stabilizers and flavors can also be added to enhance flavor, sensory appeal, mouth-feel, ingredient solubilization and product appearance. A method of making the beverages is also described. A method of using Carbon Dioxide and Nitrogen to reduce bacterial counts and reduce degradation of essential nutrients in dairy beverages with or without pasteurization is also disclosed. | 10-06-2011 |
20130273199 | BEVERAGE AND METHOD FOR PRODUCING A SPARKLING BEVERAGE WHICH IS A NUTRITIOUS ALTERNATIVE TO MILK WITH ALL THE NUTRITION OF MILK PLUS ANTRHOCYANINS - Dairy or non-diary based fortified carbonated beverage solutions that supply essential nutrients in the human diet. The solution contains per 354 ml, calcium, magnesium and potassium ions in the form of salts, Anthrocyanins, Amelanchia alnifolia Liquid Extract and optionally vitamins A, D, C, lutein, zeaxanthin and folic acid in specified amounts to provide dietary supplementation. Sweeteners, stabilizers, flavors and carbonation can also be added to enhance flavor, taste, mouth-feel, ingredient solubilization and product appearance. A method of making the beverages is also described. A method of using carbonation to reduce bacterial counts and reduce degradation of essential nutrients in milk-based beverages with or without pasteurization is also disclosed. Finally, a method of stabilization the mixture and achieving a higher level of purification by quantitatively separating the mixture into solid and liquid phase, treating each phase separately and then quantitatively recombining the phases before the addition of other ingredients. | 10-17-2013 |
20130337113 | CARBONATED DAIRY NUTRIENT BEVERAGE AND METHOD OF MAKING A CARBONATED DAIRY NUTRIENT BEVERAGE TO SUPPLY THE SAME QUALITATIVE NUTRITION CONTAINED IN SKIM MILK TO THE HUMAN DIET - Carbonated dairy nutrient beverage solutions that supply essential nutrients in the human diet. The solutions may contain per 8 oz., calcium, magnesium and potassium ions in the form of salts, vitamins A Palmitate, D3, C, and optionally lutein, zeaxanthin and folic acid in specified amounts to provide dietary supplementation. Sweeteners, stabilizers and flavors can also be added to enhance flavor, sensory appeal, mouth-feel, ingredient solubilization and product appearance. A method of making the beverages is also described. A method of using Carbon Dioxide, Nitrogen and Argon gases to reduce sodium content, bacterial counts and reduce degradation of essential nutrients in dairy beverages with or without Pasteurization is also disclosed. | 12-19-2013 |
Patent application number | Description | Published |
20100041067 | Reaction Sensing in Living Cells - Chemical reactions occurring within a living cell are measured in a manner that does not affect the viability of the cell or the reaction under study. In one embodiment, one or more sensors are introduced into the cell and/or covalently associated with the exterior cell membrane. The sensor(s) emit an observable signal indicating a value of a parameter associated with the chemical reaction, e.g., the concentration of a reaction product. Because cell viability is not compromised, the cell may be stimulated (e.g., by subjection to an agonist or antagonist, a pathogen, a pharmaceutical compound, or a potential toxin) so as to affect the reaction under study. | 02-18-2010 |
20100227334 | Reaction sensing in living cells - Chemical reactions occurring within a living cell are measured in a manner that does not affect the viability of the cell or the reaction under study. In one embodiment, one or more sensors are introduced into the cell and/or covalently associated with the exterior cell membrane. The sensor(s) emit an observable signal indicating a value of a parameter associated with the chemical reaction, e.g., the concentration of a reaction product. Because cell viability is not compromised, the cell may be stimulated (e.g., by subjection to an agonist or antagonist, a pathogen, a pharmaceutical compound, or a potential toxin) so as to affect the reaction under study. | 09-09-2010 |
Patent application number | Description | Published |
20090142274 | Intracellular nanosensors and methods for their introduction into cells - The invention provides ion-selective sensors capable of selectively measuring ions, e.g., Na | 06-04-2009 |
20090155183 | Sensors for the detection of diols and carbohydrates - The systems and methods disclosed herein include a sensor particle for detecting the presence of a chelatable analyte, such as glucose, wherein the sensor comprises a chromophore and a fluorescent component, such as a quantum dot. The sensor particle further comprises moieties that bind both a clelatable analyte and chromophore reversibly and competitively. In the presence of the chelatable analyte, the moieties bind the analyte, and release the chromophore. The chromophore absorbs photons of one wavelength in a free state but of a different wavelength in a bound state, and is selected to operate with the fluorescent component such that the chromophore absorbs emissions of the fluorescent substance in only one of the bound and unbound states. In certain aspects, the invention comprises methods for detecting the presence of a chelatable analyte in a medium such as water, blood plasma and urine, using the sensor particles of the invention. | 06-18-2009 |
20100105075 | SYSTEMS AND METHODS OF VOLTAGE-GATED ION CHANNEL ASSAYS - Systems and methods are provided for optically measuring ion concentrations in biological samples. The systems and methods employ polymer-based optical ion sensors that include ion-selective ionophores and a pH sensitive chromionophore. Electrodes are providing for electrically stimulating the biological samples. | 04-29-2010 |
20100221188 | Coated sensors and methods related thereto - The invention provides coated sensors for detecting the presence of analytes. The sensor comprises one or more fluorescent sources, such as one or more quantum dots or one or more fluorescent dyes, a polymeric matrix, a surface coating, and one or more analyte sensing components. The surface coating may be a conformal polymeric film, permeable to the analyte, which may be deposited via a solventless process such as initiated chemical vapor deposition or photoinitiated chemical vapor deposition. The surface coating may increase the biocompatibility of the sensor, reduce nonspecific protein adsorption, and/or sequester functional sensor components within the sensor. The invention also provides methods for detecting the presence of an analyte with coated sensors of the invention. | 09-02-2010 |
20110189770 | Endosome-Disrupting Compositions and Conjugates - The present invention is directed to an endosome-disrupting conjugate, and methods of delivery of said conjugate to cells. The conjugates of the invention comprise a payload and an endosome-disrupting component of which the latter comprises a plurality of moieties that react under acidic conditions, e.g., within an endosome, to release gaseous endosome-disrupting molecules, e.g., CO | 08-04-2011 |
20130197326 | Compositions And Methods For Measurement of Analytes - Disclosed herein are compositions comprising an oblong optode sensing agent. The oblong optode sensing agent comprises a core and a semipermeable membrane, wherein the core comprises one or more sensors configured to bind to an analyte. In addition, methods of making and detecting the oblong optode sensing agents are disclosed. | 08-01-2013 |
20130260014 | COATED SENSORS AND METHODS RELATED THERETO - The invention provides coated sensors for detecting the presence of analytes. The sensor comprises one or more fluorescent sources, such as one or more quantum dots or one or more fluorescent dyes, a polymeric matrix, a surface coating, and one or more analyte sensing components. The surface coating may be a conformal polymeric film, permeable to the analyte, which may be deposited via a solventless process such as initiated chemical vapor deposition or photoinitiated chemical vapor deposition. The surface coating may increase the biocompatibility of the sensor, reduce nonspecific protein adsorption, and/or sequester functional sensor components within the sensor. The invention also provides methods for detecting the presence of an analyte with coated sensors of the invention. | 10-03-2013 |
20150030544 | Enzymatic Nanosensor Compositions and Methods - Disclosed herein are compositions including a nanosensor that is sensitive to an analyte such that the nanosensor emits a fluorescent signal upon detecting the analyte, and a catalytic agent that catalyzes a reaction in which a target substrate is converted into one or more products, such that at least one of the one or more products is the analyte. In addition, methods of using the nanosensor-catalytic agent compositions to detect a target substrate are disclosed. | 01-29-2015 |
Patent application number | Description | Published |
20090246342 | METHOD FOR PROCESSING FLUID DAIRY, FRUIT OR VEGETABLE JUICES AND BEVERAGE CONCENTRATES FORMULATED FOR BEVERAGE PRODUCTS INTENDED FOR HUMAN CONSUMPTION TO PROTECT AGAINST DELIBERATE CONTAMINATION WITH PATHOGENIC AGROTERRORISM AGENTS - A method for purifying fluids without compromising the components of the fluid is disclosed. Fluid dairy, fruit, vegetable and/or beverage concentrates are processed using pasteurization and filtration steps selectively applied to separate phase-separated components of the fluid to eliminate contaminants including agro- and biological terrorism contaminants such as bacteria and viruses. | 10-01-2009 |
20110244076 | CARBONATED DAIRY NUTRIENT BEVERAGE AND METHOD OF MAKING A CARBONATED DAIRY NUTRIENT BEVERAGE TO SUPPLY THE SAME NUTRITION OF SKIM MILK IN THE HUMAN DIET - Carbonated dairy nutrient beverage solutions that supply essential nutrients in the human diet are disclosed. The solutions may contain per 8 oz., calcium, magnesium and potassium ions in the form of salts, vitamins A, D, C, and optionally lutein, zeaxanthin and folic acid in specified amounts to provide dietary supplementation. Sweeteners, stabilizers and flavors can also be added to enhance flavor, sensory appeal, mouth-feel, ingredient solubilization and product appearance. A method of making the beverages is also described. A method of using Carbon Dioxide and Nitrogen to reduce bacterial counts and reduce degradation of essential nutrients in dairy beverages with or without pasteurization is also disclosed. | 10-06-2011 |
20130273199 | BEVERAGE AND METHOD FOR PRODUCING A SPARKLING BEVERAGE WHICH IS A NUTRITIOUS ALTERNATIVE TO MILK WITH ALL THE NUTRITION OF MILK PLUS ANTRHOCYANINS - Dairy or non-diary based fortified carbonated beverage solutions that supply essential nutrients in the human diet. The solution contains per 354 ml, calcium, magnesium and potassium ions in the form of salts, Anthrocyanins, Amelanchia alnifolia Liquid Extract and optionally vitamins A, D, C, lutein, zeaxanthin and folic acid in specified amounts to provide dietary supplementation. Sweeteners, stabilizers, flavors and carbonation can also be added to enhance flavor, taste, mouth-feel, ingredient solubilization and product appearance. A method of making the beverages is also described. A method of using carbonation to reduce bacterial counts and reduce degradation of essential nutrients in milk-based beverages with or without pasteurization is also disclosed. Finally, a method of stabilization the mixture and achieving a higher level of purification by quantitatively separating the mixture into solid and liquid phase, treating each phase separately and then quantitatively recombining the phases before the addition of other ingredients. | 10-17-2013 |
20130337113 | CARBONATED DAIRY NUTRIENT BEVERAGE AND METHOD OF MAKING A CARBONATED DAIRY NUTRIENT BEVERAGE TO SUPPLY THE SAME QUALITATIVE NUTRITION CONTAINED IN SKIM MILK TO THE HUMAN DIET - Carbonated dairy nutrient beverage solutions that supply essential nutrients in the human diet. The solutions may contain per 8 oz., calcium, magnesium and potassium ions in the form of salts, vitamins A Palmitate, D3, C, and optionally lutein, zeaxanthin and folic acid in specified amounts to provide dietary supplementation. Sweeteners, stabilizers and flavors can also be added to enhance flavor, sensory appeal, mouth-feel, ingredient solubilization and product appearance. A method of making the beverages is also described. A method of using Carbon Dioxide, Nitrogen and Argon gases to reduce sodium content, bacterial counts and reduce degradation of essential nutrients in dairy beverages with or without Pasteurization is also disclosed. | 12-19-2013 |
Patent application number | Description | Published |
20100029634 | Chemokine Receptor Modulators - The invention provides compounds of Formula (I) | 02-04-2010 |
20120171245 | INHIBITORS OF INFLUENZA VIRUSES REPLICATION - Methods of inhibiting the replication of influenza viruses in a biological sample or patient, of reducing the amount of influenza viruses in a biological sample or patient, and of treating influenza in a patient, comprises administering to said biological sample or patient an effective amount of a compound represented by Structural Formula (I): | 07-05-2012 |
20130172330 | Chemokine Receptor Modulators - The invention provides compounds of Formula (I) | 07-04-2013 |
20130345218 | INHIBITORS OF INFLUENZA VIRUSES REPLICATION - Methods of inhibiting the replication of influenza viruses in a biological sample or patient, of reducing the amount of influenza viruses in a biological sample or patient, and of treating influenza in a patient, comprises administering to said biological sample or patient an effective amount of a compound represented by Structural Formula (I): | 12-26-2013 |
20140005192 | INHIBITORS OF INFLUENZA VIRUSES REPLICATION | 01-02-2014 |
20140005197 | INHIBITORS OF INFLUENZA VIRUSES REPLICATION | 01-02-2014 |
20140094473 | INHIBITORS OF INFLUENZA VIRUSES REPLICATION - Methods of inhibiting the replication of influenza viruses in a biological sample or patient, of reducing the amount of influenza viruses in a biological sample or patient, and of treating influenza in a patient, comprises administering to said biological sample or patient an effective amount of a compound represented by Structural Formula (I): | 04-03-2014 |
20140142119 | INHIBITORS OF INFLUENZA VIRUSES REPLICATION - Methods of inhibiting the replication of influenza viruses in a biological sample or patient, of reducing the amount of influenza viruses in a biological sample or patient, and of treating influenza in a patient, comprises administering to said biological sample or patient an effective amount of a compound represented by Structural Formula (I): | 05-22-2014 |
20140296201 | INHIBITORS OF INFLUENZA VIRUSES REPLICATION - Methods of inhibiting the replication of influenza viruses in a biological sample or patient, of reducing the amount of influenza viruses in a biological sample or patient, and of treating influenza in a patient, comprises administering to said biological sample or patient an effective amount of a compound represented by Structural Formula (I): | 10-02-2014 |
20150191468 | INHIBITORS OF INFLUENZA VIRUSES REPLICATION - Methods of inhibiting the replication of influenza viruses in a biological sample or patient, of reducing the amount of influenza viruses in a biological sample or patient, and of treating influenza in a patient, comprises administering to said biological sample or patient an effective amount of a compound represented by Structural Formula (I): | 07-09-2015 |
Patent application number | Description | Published |
20100039532 | In Flight Autofocus System And Method - A camera module and method for focusing a tunable lens configured to continuously vary its optical power in response to a drive signal. A drive circuit generates the drive signal so that the tunable lens performs a continuous scan of its optical power. An image sensor is configured to acquire light images passing through the tunable lens, and to convert the light images to image signals during the continuous scan. A processor is configured to generate focus scores of the acquired light images using the image signals during the continuous scan. The processor is configured to determine from the focus scores a peak focus score achieved or achievable, and to instruct the drive circuit to adjust the drive signal so that the tunable lens settles at a value of the optical power that corresponds to the peak focus score. | 02-18-2010 |
20110090415 | TUNABLE LIQUID CRYSTAL OPTICAL DEVICE - A liquid crystal optical device has a layered structure with split liquid crystal layers having alignment surfaces that define in a liquid crystal material pre-tilt angles of opposite signs. Four liquid crystal layers can provide two directions of linear polarization. In the case of a lens, the device can be a gradient index lens, and the alignment surfaces can have a spatially uniform pre-tilt. | 04-21-2011 |
20120140037 | MOTIONLESS ADAPTIVE STEREOSCOPIC SCENE CAPTURE WITH TUNEABLE LIQUID CRYSTAL LENSES AND STEREOSCOPIC AUTO-FOCUSING METHODS - A motionless adaptive focus stereoscopic scene capture apparatus employing tunable liquid crystal lenses is provided. The apparatus includes at least two image sensors preferably fabricated as a monolithic stereo image capture component and at least two corresponding tunable liquid crystal lenses preferably fabricated as a monolithic focus adjustment component. Using a variable focus tunable liquid crystal lens at each aperture stop provides constant magnification focus control. Controlled spatial variance of a spatially variant electric field applied to the liquid crystal of each tunable liquid crystal lens provides optical axis shift enabling registration between stereo images. A controller implements coupled auto-focusing methods employing multiple focus scores derived from at least two camera image sensors and providing multiple tunable liquid crystal lens drive signals for synchronous focus acquisition of a three dimensional scene. Wafer manufacture provides a compact stereoscopic image capture apparatus for endoscopic surgery, optical inspection and entertainment applications. | 06-07-2012 |
20120140044 | MOTIONLESS ADAPTIVE STEREOSCOPIC SCENE CAPTURE WITH TUNEABLE LIQUID CRYSTAL LENSES AND STEREOSCOPIC AUTO-FOCUSING METHODS - A motionless adaptive focus stereoscopic scene capture apparatus employing tuneable liquid crystal lenses is provided. The apparatus includes at least two image sensors preferably fabricated as a monolithic stereo image capture component and at least two corresponding tuneable liquid crystal lenses preferably fabricated as a monolithic focus adjustment component. Using a variable focus tuneable liquid crystal lens at each aperture stop provides constant magnification focus control. Controlled spatial variance of a spatially variant electric field applied to the liquid crystal of each tuneable liquid crystal lens provides optical axis shift enabling registration between stereo images. A controller implements coupled auto-focusing methods employing multiple focus scores derived from at least two camera image sensors and providing multiple tuneable liquid crystal lens drive signals for synchronous focus acquisition of a three dimensional scene. Wafer manufacture provides a compact stereoscopic image capture apparatus for endoscopic surgery, optical inspection and entertainment applications. | 06-07-2012 |
20120200764 | CAMERA MODULE WITH TOLERANCE ADJUSTMENT USING EMBEDDED ACTIVE OPTICS - A focus free camera module uses fixed lenses within a housing that are combined with an electrically controllable active optical element, such as a tunable liquid crystal lens. The fixed lenses provide a desired amount of optical power, but the manufacturing tolerances of the module are insufficient to ensure a proper focus of an image on an image sensor. The active optical element is therefore used to compensate for any variations in the optical power to achieve the desired focus. To ensure an effective compensation, the module may be constructed so that, when the variation in optical power due to manufacturing tolerances is at a maximum, the desired focus is achieved when the active optical element is at zero optical power. All other variations may then be compensated by adjusting the active optical element to increase its optical power. | 08-09-2012 |
20130033673 | METHOD AND APPARATUS FOR TESTING OPERATION OF AN OPTICAL LIQUID CRYSTAL DEVICE - Methods and apparatus for testing operation of a single or multiple tunable active optical device(s) operated by one or more driving electrodes are described Test methods and apparatus are provided for device testing without necessarily requiring direct physical contact with the driving electrodes Testing subjects devices to incident light along an optical path and to an external electric field applied to the device producing a dipolar charge distribution within the electrodes, causing the device to operate The effect of device operation on incident light is optically sensed The sensed effect is analyzed to identify device defects Test methods and apparatus are provided for testing multiple unsingulated devices during fabrication employing a strip contact structure having contact strips connected to multiple devices and extending to wafer edges, such that singulating devices leaves portions of the strip contact structure exposed on device dice edges providing electrical contacts in use. | 02-07-2013 |
20140036183 | TUNABLE LIQUID CRYSTAL OPTICAL DEVICE - A liquid crystal optical device has a layered structure with split liquid crystal layers having alignment surfaces that define in a liquid crystal material pre-tilt angles of opposite signs. Four liquid crystal layers can provide two directions of linear polarization. In the case of a lens, the device can be a gradient index lens, and the alignment surfaces can have a spatially uniform pre-tilt. | 02-06-2014 |
Patent application number | Description | Published |
20100105671 | C7-fluoro substituted tetracycline compounds - The present invention is directed to a compound represented by Structural Formula (A): | 04-29-2010 |
20110118302 | PREPARATION AND USE OF BIPHENYL-4-YL-CARBONYLAMINO ACID DERIVATIVES FOR THE TREATMENT OF OBESITY - This invention relates to certain biphenyl-4-yl carbonylamino acid compounds, compositions, and methods for treating or preventing obesity and related diseases. | 05-19-2011 |
20120071652 | Novel Piperazines, Pharmaceutical Compositions and Methods of Use Thereof - Disclosed are novel piperazine derivatives that act as agonists of the α7 nAChR. Also disclosed are pharmaceutical compositions, methods of treating inflammatory conditions, methods of treating CNS disorders, methods for inhibiting cytokine release from mammalian cells and methods for the preparation of the novel compounds. | 03-22-2012 |
20120108569 | 8-AZA Tetracycline Compounds - The present invention is directed to a compound represented by Structural Formula (I) or a pharmaceutically acceptable salt thereof. The variables for Structural Formula I are defined herein. Also described is a pharmaceutical composition comprising the compound of Structural Formula I and its therapeutic use. | 05-03-2012 |
20120115819 | Pentacycline Compounds - The present invention is directed to a compound represented by Structural Formula (I): or a pharmaceutically acceptable salt thereof. The variables for Structural Formula (I) are defined herein. Also described is a pharmaceutical composition comprising the compound of Structural Formula (I) and its therapeutic use. | 05-10-2012 |
20120135968 | Tetracycline Compounds - The present invention is directed to a compound represented by Structural Formula (I): or a pharmaceutically acceptable salt thereof. The variables for Structural Formula I are defined herein. Also described is a pharmaceutical composition comprising the compound of Structural Formula I and its therapeutic use. | 05-31-2012 |
20120302527 | C7-Fluoro Substituted Tetracycline Compounds - The present invention is directed to a compound represented by Structural Formula (A): | 11-29-2012 |
20130109657 | C7-Fluoro Substituted Tetracycline Compounds | 05-02-2013 |
20130345178 | 8-AZA Tetracycline Compounds - The present invention is directed to a compound represented by Structural Formula (I): | 12-26-2013 |
20140343059 | NOVEL PIPERAZINES, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREOF - Disclosed are novel piperazine derivatives that act as agonists of the α7 nAChR. Also disclosed are pharmaceutical compositions, methods of treating inflammatory conditions, methods of treating CNS disorders, methods for inhibiting cytokine release from mammalian cells and methods for the preparation of the novel compounds. | 11-20-2014 |
Patent application number | Description | Published |
20100116422 | METHOD OF FORMING LARGE DIAMETER THERMOPLASTIC SEAL - A method of forming a seal ring includes heating an extruded rod to a temperature above a glass transition temperature. The extruded rod has first and second ends. The method further includes bending the extruded rod into a circular structure while the temperature is above the glass transition temperature, joining the first and second ends of the extruded rod to form a semi-finished ring, and annealing the semi-finished ring. | 05-13-2010 |
20100117310 | LARGE DIAMETER THERMOPLASTIC SEAL - A seal ring includes a weld and a thermoplastic material. The thermoplastic material has a weld elongation-at-break of at least 3%. The thermoplastic material can have a glass transition temperature of at least 100° C. The thermoplastic material with the weld can have a weld elongation-at-break of at least 3%. The seal ring can have a circumference of at least 0.62 meters. The seal ring can have a coefficient of friction of not greater than 0.45. | 05-13-2010 |
20120106882 | Cast Fluoropolymer Film for Bushings - A method includes casting a friction reducing layer on a carrier, and casting an adhesive layer overlying the friction reducing layer to form a multilayer cast film. The method further includes laminating the multilayer cast film to the load bearing substrate with the load bearing substrate to form a composite and shaping the composite. The load bearing substrate is closer to the adhesive layer than to the friction reducing layer. | 05-03-2012 |
20120282437 | FILM FOR PHOTOVOLTAIC DEVICES - A textured film is provided. The textured film includes a first layer forming an outer surface and including a fluoropolymer. A second layer includes an encapsulant layer. The first layer and the second layer are mechanically textured to provide a plurality of surface features on the outer surface and extend into the second layer. The film can be applied as a textured film overlying an active component of a photovoltaic device. | 11-08-2012 |
20140087115 | Large Diameter Thermoplastic Seal - A seal ring includes a weld and a thermoplastic material. The thermoplastic material has a weld elongation-at-break of at least 3%. The thermoplastic material can have a glass transition temperature of at least 100° C. The thermoplastic material with the weld can have a weld elongation-at-break of at least 3%. The seal ring can have a circumference of at least 0.62 meters. The seal ring can have a coefficient of friction of not greater than 0.45. | 03-27-2014 |
Patent application number | Description | Published |
20110041609 | Offset Detection and Compensation for Micromachined Inertial Sensors - Error sources relating to the drive signal applied to the resonator of an inertial sensor, such as in-phase offset errors relating to the drive signal and/or electronic pass-through of the drive signal to accelerometer sense electronics, are detected by modulating the drive signal and sensing accelerometer signals that are induced by the modulated drive signal. Error sources related to aerodynamics of an inertial sensor resonator are detected by modulating the distance between the resonator and the underlying substrate and sensing accelerometer signals that are induced by such modulation. Compensating signals may be provided to substantially cancel errors caused by such error sources. | 02-24-2011 |
20110115498 | Detection and Mitigation of Particle Contaminants in MEMS Devices - Detecting and/or mitigating the presence of particle contaminants in a MEMS device involves including MEMS structures that in normal operation are robust against the presence of particles but which can be made sensitive to that presence during a test mode prior to use, e.g., by switching the impedance of sensitive structures between an exceptionally sensitive condition during test and a normal sensitivity during operation; surrounding sensitive nodes with guard elements that are at the same potential as those nodes during operation, thereby offering protection against bridging particles, but are at a very different potential during test and reveal the particles by their resulting leakage currents; extending the sensitive nodes to interdigitate with or otherwise extend adjacent to the guard structures, which neither contribute to nor detract from the device operation but cover otherwise open areas with detection means during test; and/or converting benign areas in which particles might become trapped undetectably by electric fields during test to field-free regions by extending otherwise non-functional conductive layers so that the particles can then be moved into detection locations by providing some mechanical disturbance. | 05-19-2011 |
20130167639 | Inertial Sensors Using Piezoelectric Transducers - An inertial sensor includes driving piezoelectric transducers for enabling an oscillation of a resonator, sensing piezoelectric transducers for enabling a detection of a movement of the inertial sensor, and piezoelectric compensating elements substantially equidistantly among the driving and the sensing piezoelectric transducers, wherein the compensating elements and the resonator form corresponding capacitors having capacitive gaps, and wherein, during the oscillation of the resonator, changes in electrostatic charges stored in the capacitors are measured with the compensating elements and are modified so as to modify the oscillation of the resonator. | 07-04-2013 |
20130167642 | Piezoelectric Transducers - An inertial sensor includes driving piezoelectric transducers for enabling an oscillation of a resonator, sensing piezoelectric transducers for enabling a detection of a movement of the inertial sensor, and piezoelectric compensating elements substantially equidistantly among the driving and the sensing piezoelectric transducers, wherein the compensating elements and the resonator form corresponding capacitors having capacitive gaps, and wherein, during the oscillation of the resonator, changes in electrostatic charges stored in the capacitors are measured with the compensating elements and are modified so as to modify the oscillation of the resonator. | 07-04-2013 |
20130168675 | Detection and Mitigation of Particle Contaminants in MEMS Devices - Detecting and/or mitigating the presence of particle contaminants in a MEMS device involves including MEMS structures that in normal operation are robust against the presence of particles but which can be made sensitive to that presence during a test mode prior to use, e.g., by switching the impedance of sensitive structures between an exceptionally sensitive condition during test and a normal sensitivity during operation; surrounding sensitive nodes with guard elements that are at the same potential as those nodes during operation, thereby offering protection against bridging particles, but are at a very different potential during test and reveal the particles by their resulting leakage currents; extending the sensitive nodes to interdigitate with or otherwise extend adjacent to the guard structures, which neither contribute to nor detract from the device operation but cover otherwise open areas with detection means during test; and/or converting benign areas in which particles might become trapped undetectably by electric fields during test to field-free regions by extending otherwise non-functional conductive layers so that the particles can then be moved into detection locations by providing some mechanical disturbance. | 07-04-2013 |
20140060186 | Detection and Mitigation of Aerodynamic Error Sources for Micromachined Inertial Sensors - Error sources related to aerodynamics of an inertial sensor resonator are detected by modulating the distance between the resonator and the underlying substrate and sensing modulated error signals in the accelerometer that are induced by such modulation. Compensating signals may be provided to substantially cancel errors caused by such error sources. | 03-06-2014 |
20140250969 | Spread-Spectrum MEMS Self-Test System and Method - A MEMS sensor includes a micro-electromechanical structure, a detection circuit, and a self-test circuit to test the health of the MEMS sensor during runtime operations. The self-test circuit is configured to inject into the micro-electromechanical structure a plurality of injected test signals that are broad-band frequency-varying frequency signals, which are based on spread spectrum based modulation. The injected test signals may a magnitude that is below an observable threshold of the sensor signal as well as a test-signal bandwidth that overlaps with a substantial portion of the sensor bandwidth, including the stimulus of interest. | 09-11-2014 |
20140260611 | XY-Axis Gyroscopes with Electrode Configuration for Detecting Quadrature Errors and Out-of-Plane Sense Modes - Various embodiments include feedback circuits for tuning the drive modes of a shell-type gyroscope, while other embodiments include separate circuits for tuning the sense mode of a shell-type gyroscope to reduce or avoid quadrature errors. Still other embodiments include circuits to excite the sense modes (i.e., the out-of-plane modes) of a gyroscope without requiring the application of a rotation to the gyroscope, to ensure that the sense modes are aligned with the sense electrodes. | 09-18-2014 |
20150122024 | Accelerometer with Offset Compensation - An accelerometer has a movable mass suspended above a substrate, and a variable acceleration capacitor supported by the substrate. The movable mass has a mass anchor securing the mass to the substrate, while the acceleration capacitor has both a stationary finger extending from the substrate, and a movable finger extending from the movable mass. The accelerometer also has a variable stress capacitor, which also includes the stress finger, for determining movement of the mass anchor relative to the substrate. | 05-07-2015 |
Patent application number | Description | Published |
20080251276 | DATA CABLE WITH CROSS-TWIST CABLED CORE PROFILE - Cables including a plurality of twisted pairs of insulated conductors and a jacket surrounding the plurality of twisted pairs of insulated conductors, the jacket including a plurality of protrusions extending away from an inner circumferential surface of the jacket toward a center of the cable. The plurality of protrusions are configured so as to hold the plurality of twisted pairs away from the inner circumferential surface of the jacket, and may provide an air gap between the plurality of twisted pairs of insulated conductors and the inner circumferential surface of the jacket, thereby reducing susceptibility of the plurality of twisted pairs to alien near end crosstalk. | 10-16-2008 |
20090014202 | DATA CABLE WITH CROSS-TWIST CABLED CORE PROFILE - Cables including a plurality of twisted pairs of insulated conductors, a separator disposed among the plurality of twisted pairs so as to physically separate a first twisted pair from a second twisted pair, and a jacket surrounding the plurality of twisted pairs and the separator. The jacket may include a plurality of protrusions extending away from an inner circumferential surface of the jacket toward a center of the cable. The plurality of protrusions are configured so as to hold the plurality of twisted pairs away from the inner circumferential surface of the jacket, and may provide an air gap between the plurality of twisted pairs of insulated conductors and the inner circumferential surface of the jacket, thereby reducing susceptibility of the plurality of twisted pairs to alien near end crosstalk. In one example, a boundary of the air gap adjacent the inner circumferential surface of the jacket is arc shaped. | 01-15-2009 |
20090071690 | ELECTRICAL CABLE COMPRISING GEOMETRICALLY OPTIMIZED CONDUCTORS - A number of examples of insulated conductors having geometrically optimized shapes and form factors, that may be used in twisted-pair cables and other types of communication cable to enhance the performance of, and/or reduce the cost of manufacturing such cables. | 03-19-2009 |
20090071691 | TWISTED PAIR CABLE HAVING IMPROVED CROSSTALK ISOLATION - A cable that provides reduced alien crosstalk between similar twisted pairs in cables that are in close proximity to one another and/or crosstalk between twisted pairs of the cable. In one example, a cable includes first, second and third twisted pairs, a shaped filler including a body portion and a plurality of tines extending outward from the body portion, the plurality of tines defining a plurality of channels in which the twisted pairs are individually disposed, and an outer jacket surrounding the twisted pairs and the shaped filler, wherein the shaped filler is constructed such that the body portion provides a first spacing between the first twisted pair and the second twisted pair, and one of the plurality of tines provides a second spacing between the second twisted pair and the third twisted pair, with the filler configured such that the second spacing is substantially smaller than the first spacing. | 03-19-2009 |
20090120664 | DATA CABLE WITH CROSS-TWIST CABLED CORE PROFILE - Cables including a plurality of twisted pairs of insulated conductors, a separator disposed among the plurality of twisted pairs so as to physically separate a first twisted pair from a second twisted pair, and a jacket surrounding the plurality of twisted pairs and the separator. The jacket may include a plurality of protrusions extending away from an inner circumferential surface of the jacket toward a center of the cable. The plurality of protrusions are configured so as to hold the plurality of twisted pairs away from the inner circumferential surface of the jacket, and may provide an air gap between the plurality of twisted pairs of insulated conductors and the inner circumferential surface of the jacket. In one example, a boundary of the air gap adjacent the inner circumferential surface of the jacket is arc shaped. | 05-14-2009 |
20100147550 | DATA CABLE WITH STRIATED JACKET - Cables including a plurality of twisted pairs of insulated conductors, a separator disposed among the plurality of twisted pairs so as to physically separate a first twisted pair from a second twisted pair, and a jacket surrounding the plurality of twisted pairs and the separator. The jacket may include a plurality of protrusions extending away from an inner circumferential surface of the jacket toward a center of the cable. The plurality of protrusions are configured so as to hold the plurality of twisted pairs away from the inner circumferential surface of the jacket, and may provide an air gap between the plurality of twisted pairs of insulated conductors and the inner circumferential surface of the jacket. | 06-17-2010 |